공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 바이러스학 및 세균학 시장 : 기술, 질환, 최종사용자, 지역별, 경쟁, 예측 및 기회(2025년)

Global Virology and Bacteriology Market, By Technology, By Disease, By End User, By Region, Competition, Forecast & Opportunities, 2025

리서치사 TechSci Research
발행일 2020년 08월 상품 코드 953899
페이지 정보 영문 126 Pages
가격
US $ 4,450 ₩ 5,033,000 Unprintable PDF and Excel (Single User License)
US $ 5,450 ₩ 6,165,000 PDF and Excel (Multi-User License)
US $ 9,450 ₩ 10,689,000 PDF and Excel (Custom Research License)

TechSci Research 보고서는 10% Customization 서비스가 포함되어 있습니다. 보고서에 포함돼 있지 않은 리서치 데이터와 시장 동향을 추가적으로 요청할 수 있습니다. 자세한 사항은 문의하여 주시기 바랍니다.



세계의 바이러스학 및 세균학 시장 : 기술, 질환, 최종사용자, 지역별, 경쟁, 예측 및 기회(2025년) Global Virology and Bacteriology Market, By Technology, By Disease, By End User, By Region, Competition, Forecast & Opportunities, 2025
발행일 : 2020년 08월 페이지 정보 : 영문 126 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 바이러스학 및 세균학 시장은 2021-2025년간 약 12%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예측됩니다.

세계의 바이러스학(Virology) 및 세균학(Bacteriology) 시장에 대해 조사했으며, 시장 규모와 예측, 점유율과 동향, 성장요인, 기술·질환·최종사용자·지역별 시장 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 전해드립니다.

목차

제1장 제품 개요

제2장 조사 방법

제3장 코로나19(COVID-19)의 영향

제4장 개요

제5장 고객의 견해(VOC)

제6장 시장 전망

  • 시장 규모와 예측
    • 매출별
  • 시장 점유율과 예측
    • 기술별(분자진단, 면역분석법, 영상진단, 정보기술)
    • 질환 별(호흡기, 요로 및 혈류질환, 위장질환 및 치주질환, 성감염증)
    • 최종사용자별(클리닉, 병원, 진단센터, 연구, 혈액은행)
    • 기업별(2019년)
    • 지역별
  • 시장 매력 지수

제7장 아시아태평양

제8장 유럽

제9장 북미

제10장 남미

제11장 중동 및 아프리카

제12장 시장 역학

  • 성장요인
  • 과제

제13장 시장 동향

제14장 특허 분석

제15장 경쟁 구도

  • Fujirebio Diagnostics Inc.
  • Cepheid Inc.
  • DiaSorin S.p.A.
  • Bio-Rad Laboratories Inc.
  • Thermo Fisher Scientific Inc.
  • Scienion AG
  • Grifols S.A.
  • Qiagen N.V.
  • Eiken Chemical Co. Ltd.
  • Sequenom Inc.
  • bioMerieux SA
  • Siemens AG
  • Hologic Inc.
  • Diamedix Corporation
  • Leica Biosystems Nussloch GmbH
  • F. Hoffmann-La Roche AG
  • Abbott Laboratories
  • GSK Biologicals SA

제16장 전략적 제안

LSH 20.09.04

List of Figures

  • Figure 1: Global Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 2: Global Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 3: Global Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 4: Global Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 5: Global Virology and Bacteriology Market Size, By Company (USD Million), 2015-2025F
  • Figure 6: Global Virology and Bacteriology Market Size, By Region (USD Million), 2015-2025F
  • Figure 7: Global Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 8: North America Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 9: North America Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 10: North America Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 11: North America Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 12: North America Virology and Bacteriology Market Size, By Country (USD Million), 2015-2025F
  • Figure 13: North America Virology and Bacteriology Market Size Attractiveness Index, By Country, By Value, 2015-2025F
  • Figure 14: North America Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 15: United States Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 16: United States Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 17: United States Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 18: United States Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 19: United States Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 20: Canada Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 21: Canada Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 22: Canada Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 23: Canada Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 24: Canada Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 25: Mexico Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 26: Mexico Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 27: Mexico Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 28: Mexico Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 29: Mexico Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 30: Europe Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 31: Europe Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 32: Europe Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 33: Europe Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 34: Europe Virology and Bacteriology Market Size, By Country (USD Million), 2015-2025F
  • Figure 35: Europe Virology and Bacteriology Market Size Attractiveness Index, By Country, By Value, 2015-2025F
  • Figure 36: Europe Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 37: France Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 38: France Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 39: France Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 40: France Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 41: France Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 42: Germany Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 43: Germany Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 44: Germany Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 45: Germany Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 46: Germany Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 47: Italy Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 48: Italy Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 49: Italy Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 50: Italy Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 51: Italy Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 52: Spain Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 53: Spain Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 54: Spain Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 55: Spain Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 56: Spain Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 57: United Kingdom Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 58: United Kingdom Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 59: United Kingdom Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 60: United Kingdom Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 61: United Kingdom Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 62: Russia Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 63: Russia Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 64: Russia Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 65: Russia Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 66: Russia Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 67: Asia-Pacific Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 68: Asia-Pacific Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 69: Asia-Pacific Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 70: Asia-Pacific Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 71: Asia-Pacific Virology and Bacteriology Market Size, By Country (USD Million), 2015-2025F
  • Figure 72: Asia-Pacific Virology and Bacteriology Market Size Attractiveness Index, By Country, By Value, 2015-2025F
  • Figure 73: Asia-Pacific Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 74: China Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 75: China Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 76: China Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 77: China Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 78: China Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 79: India Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 80: India Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 81: India Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 82: India Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 83: India Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 84: Japan Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 85: Japan Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 86: Japan Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 87: Japan Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 88: Japan Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 89: South Korea Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 90: South Korea Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 91: South Korea Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 92: South Korea Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 93: South Korea Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 94: Australia Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 95: Australia Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 96: Australia Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 97: Australia Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 98: Australia Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 99: Singapore Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 100: Singapore Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 101: Singapore Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 102: Singapore Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 103: Singapore Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 104: Middle East and Africa Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 105: Middle East and Africa Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 106: Middle East and Africa Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 107: Middle East and Africa Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 108: Middle East and Africa Virology and Bacteriology Market Size, By Country (USD Million), 2015-2025F
  • Figure 109: Middle East and Africa Virology and Bacteriology Market Size Attractiveness Index, By Country, By Value, 2015-2025F
  • Figure 110: Middle East and Africa Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 111: South Africa Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 112: South Africa Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 113: South Africa Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 114: South Africa Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 115: South Africa Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 116: Saudi Arabia Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 117: Saudi Arabia Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 118: Saudi Arabia Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 119: Saudi Arabia Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 120: Saudi Arabia Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 121: Kuwait Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 122: Kuwait Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 123: Kuwait Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 124: Kuwait Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 125: Kuwait Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 126: UAE Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 127: UAE Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 128: UAE Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 129: UAE Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 130: UAE Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 131: South America Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 132: South America Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 133: South America Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 134: South America Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 135: South America Virology and Bacteriology Market Size, By Country (USD Million), 2015-2025F
  • Figure 136: South America Virology and Bacteriology Market Size Attractiveness Index, By Country, By Value, 2015-2025F
  • Figure 137: South America Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 138: Brazil Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 139: Brazil Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 140: Brazil Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 141: Brazil Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 142: Brazil Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 143: Argentina Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 144: Argentina Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 145: Argentina Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 146: Argentina Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 147: Argentina Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 148: Colombia Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 149: Colombia Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 150: Colombia Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 151: Colombia Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 152: Colombia Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F

Title:
Global Virology and Bacteriology Market, By Technology (Molecular Diagnostics, Immunoassays, Diagnostic Imaging, Information Technology), By Disease (Respiratory System, Urinary Tract, And Bloodstream Diseases, Gastrointestinal, Sexually Transmitted Diseases), By End User (Clinics, Hospitals, Diagnostic Centers, Research Laboratories, And Blood Banks), By Region, Competition, Forecast & Opportunities, 2025.

Global virology and bacteriology market is expected to grow at a CAGR of around 12% during 2021 - 2025. The global virology and bacteriology market is driven by rising population getting affected by viral and bacterial infections. Moreover, governments across the globe are investing more on healthcare infrastructure, which is positively impacting the market growth. Also, continuous technological innovations in research and development activities is further expected to bolster the growth of market over the next few years.

The global virology and bacteriology market is segmented based on technology, disease, end user, company, and region. Based on technology, the market can be categorized into molecular diagnostics, immunoassays, diagnostic imaging, and information technology. Out of these, the molecular diagnostics segment dominated the market in 2019 and is expected to maintain its leading position during the forecast period as well. This can be ascribed to the fact that this technology allows the detection of lower amount of infectious agents, thereby detecting the infection at an early stage than was previously possible.

Major players operating in the global virology and bacteriology market include Fujirebio Diagnostics Inc., Cepheid Inc., DiaSorin S.p.A., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Scienion AG, Grifols S.A., Qiagen N.V., Eiken Chemical Co Ltd, Sequenom Inc., bioMerieux SA, Siemens AG, Hologic Inc., Diamedix Corporation, Leica Biosystems Nussloch GmbH, F. Hoffmann-La Roche AG, Abbott Laboratories, GSK Biologicals SA among others. The companies are developing advanced technologies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers, acquisitions, collaborations and partnerships.

Years considered for this report:

Historical Years: 2015 - 2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021 - 2025

Objective of the Study:

  • To analyze and estimate the market size of global virology and bacteriology market from 2015 to 2018.
  • To estimate and forecast the market size of global virology and bacteriology market from 2019 to 2025 and growth rate until 2025.
  • To classify and forecast global virology and bacteriology market based on technology, disease, end user, company and regional distribution.
  • To identify dominant region or segment in the global virology and bacteriology market.
  • To identify drivers and challenges for global virology and bacteriology market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global virology and bacteriology market.
  • To identify and analyze the profile of leading players operating in global virology and bacteriology market.
  • To identify key sustainable strategies adopted by market players in global virology and bacteriology market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of market players operating across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals/clinics which could not be identified due to the limitations of secondary research. TechSci Research analyzed the presence of all major players across the globe.

TechSci Research calculated the market size of global virology and bacteriology market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Virology and bacteriology hospitals/clinics, laboratories and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to virology and bacteriology market
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals/clinics, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global virology and bacteriology market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Technology:

Molecular Diagnostics

Immunoassays

Diagnostic Imaging

Information Technology

  • Market, By Disease:

Respiratory System

Urinary Tract, And Bloodstream Diseases

Gastrointestinal and Periodontal Diseases

Sexually Transmitted Diseases

  • Market, By Disease:

Clinics

Hospitals

Diagnostic Centers

Research Laboratories

Blood Banks

  • Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Singapore

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • Kuwait
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global virology and bacteriology market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Virology and Bacteriology Market

4. Executive Summary

5. Voice of Customer

6. Global Virology and Bacteriology Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technology (Molecular Diagnostics, Immunoassays, Diagnostic Imaging, Information Technology)
    • 6.2.2. By Disease (Respiratory System, Urinary Tract, And Bloodstream Diseases; Gastrointestinal and Periodontal Diseases; Sexually Transmitted Diseases)
    • 6.2.3. By End User (Clinics, Hospitals, Diagnostic Centers, Research Laboratories, And Blood Banks)
    • 6.2.4. By Company (2019)
    • 6.2.5. By Region
  • 6.3. Market Attractiveness Index

7. Asia-Pacific Virology and Bacteriology Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technology
    • 7.2.2. By Disease
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Asia-Pacific: Country Analysis
    • 7.3.1. China Virology and Bacteriology Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Technology
        • 7.3.1.2.2. By Disease
        • 7.3.1.2.3. By End User
    • 7.3.2. India Virology and Bacteriology Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Technology
        • 7.3.2.2.2. By Disease
        • 7.3.2.2.3. By End User
    • 7.3.3. Japan Virology and Bacteriology Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Technology
        • 7.3.3.2.2. By Disease
        • 7.3.3.2.3. By End User
    • 7.3.4. South Korea Virology and Bacteriology Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Technology
        • 7.3.4.2.2. By Disease
        • 7.3.4.2.3. By End User
    • 7.3.5. Australia Virology and Bacteriology Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Technology
        • 7.3.5.2.2. By Disease
        • 7.3.5.2.3. By End User
    • 7.3.6. Singapore Virology and Bacteriology Market Outlook
      • 7.3.6.1. Market Size & Forecast
        • 7.3.6.1.1. By Value
      • 7.3.6.2. Market Share & Forecast
        • 7.3.6.2.1. By Technology
        • 7.3.6.2.2. By Disease
        • 7.3.6.2.3. By End User

8. Europe Virology and Bacteriology Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technology
    • 8.2.2. By Disease
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Virology and Bacteriology Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Technology
        • 8.3.1.2.2. By Disease
        • 8.3.1.2.3. By End User
    • 8.3.2. Germany Virology and Bacteriology Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Technology
        • 8.3.2.2.2. By Disease
        • 8.3.2.2.3. By End User
    • 8.3.3. United Kingdom Virology and Bacteriology Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Technology
        • 8.3.3.2.2. By Disease
        • 8.3.3.2.3. By End Use
    • 8.3.4. Italy Virology and Bacteriology Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Technology
        • 8.3.4.2.2. By Disease
        • 8.3.4.2.3. By End User
    • 8.3.5. Spain Virology and Bacteriology Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Technology
        • 8.3.5.2.2. By Disease
        • 8.3.5.2.3. By End User
    • 8.3.6. Russia Virology and Bacteriology Market Outlook
      • 8.3.6.1. Market Size & Forecast
        • 8.3.6.1.1. By Value
      • 8.3.6.2. Market Share & Forecast
        • 8.3.6.2.1. By Technology
        • 8.3.6.2.2. By Disease
        • 8.3.6.2.3. By End User

9. North America Virology and Bacteriology Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technology
    • 9.2.2. By Disease
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. North America: Country Analysis
    • 9.3.1. United States Virology and Bacteriology Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Technology
        • 9.3.1.2.2. By Disease
        • 9.3.1.2.3. By End User
    • 9.3.2. Mexico Virology and Bacteriology Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Technology
        • 9.3.2.2.2. By Disease
        • 9.3.2.2.3. By End User
    • 9.3.3. Canada Virology and Bacteriology Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Technology
        • 9.3.3.2.2. By Disease
        • 9.3.3.2.3. By End User

10. South America Virology and Bacteriology Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technology
    • 10.2.2. By Disease
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Virology and Bacteriology Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Technology
        • 10.3.1.2.2. By Disease
        • 10.3.1.2.3. By End User
    • 10.3.2. Argentina Virology and Bacteriology Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Technology
        • 10.3.2.2.2. By Disease
        • 10.3.2.2.3. By End User
    • 10.3.3. Colombia Virology and Bacteriology Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Technology
        • 10.3.3.2.2. By Disease
        • 10.3.3.2.3. By End Use

11. Middle East and Africa Virology and Bacteriology Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Technology
    • 11.2.2. By Disease
    • 11.2.3. By End User
    • 11.2.4. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Virology and Bacteriology Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Technology
        • 11.3.1.2.2. By Disease
        • 11.3.1.2.3. By End User
    • 11.3.2. Saudi Arabia Virology and Bacteriology Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Technology
        • 11.3.2.2.2. By Disease
        • 11.3.2.2.3. By End User
    • 11.3.3. UAE Virology and Bacteriology Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Technology
        • 11.3.3.2.2. By Disease
        • 11.3.3.2.3. By End User
    • 11.3.4. Kuwait Virology and Bacteriology Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Technology
        • 11.3.4.2.2. By Disease
        • 11.3.4.2.3. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Patent Analysis

15. Competitive Landscape

  • 15.1. Fujirebio Diagnostics Inc.
  • 15.2. Cepheid Inc.
  • 15.3. DiaSorin S.p.A.
  • 15.4. Bio-Rad Laboratories Inc.
  • 15.5. Thermo Fisher Scientific Inc.
  • 15.6. Scienion AG
  • 15.7. Grifols S.A.
  • 15.8. Qiagen N.V.
  • 15.9. Eiken Chemical Co. Ltd.
  • 15.10. Sequenom Inc.
  • 15.11. bioMerieux SA
  • 15.12. Siemens AG
  • 15.13. Hologic Inc.
  • 15.14. Diamedix Corporation
  • 15.15. Leica Biosystems Nussloch GmbH
  • 15.16. F. Hoffmann-La Roche AG
  • 15.17. Abbott Laboratories
  • 15.18. GSK Biologicals SA

16. Strategic Recommendations

Back to Top
전화 문의
F A Q